IFG
LXRX icon

Investors Financial Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Investors Financial Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,400
Closed -$49K – 195
2020
Q4 		$49K Sell
14,400
-33,700
-70% -$64.3K 0.03% 162
2020
Q3 		$69K Buy
48,100
+32,700
+212% +$58.2K 0.05% 156
2020
Q2 		$31K Buy
+15,400
New +$30.2K 0.03% 146

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Investors Financial Group's LXRX Position: Q1 2021 in Review

Investors Financial Group sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2021, closing a stake of 14,400 shares — an estimated $49K sold.

Investors Financial Group first reported a position in LXRX in Q2 2020 and held it in 3 quarters. The position peaked at $69K in Q3 2020. 107 funds tracked by Wall St. Rank hold LXRX as of Q1 2021.

  • Investors Financial Group reported no remaining Lexicon Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Investors Financial Group sold 14,400 Lexicon Pharmaceuticals shares in Q1 2021, an estimated $49K.
  • Investors Financial Group first reported a position in Lexicon Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Investors Financial Group's Lexicon Pharmaceuticals position peaked at $69K in Q3 2020.
  • 107 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2021.

Based on Investors Financial Group's 13F filing for Q1 2021, filed 14 Apr 2021.